StonvexLoading…
StonvexStonvexStonvexCore line items from SCHL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-05-31 | Annual 2024 2024-05-31 | Annual 2023 2023-05-31 | Annual 2022 2022-05-31 |
|---|---|---|---|---|
Revenue | $1.63B | $1.59B | $1.70B | $1.64B |
Operating Income | $15.80M | $14.50M | $106.30M | $97.40M |
Net Income | $-1.90M | $12.10M | $86.30M | $80.90M |
EPS (Diluted) | $-0.07 | $0.40 | $2.49 | $2.27 |
Total Assets | $1.95B | $1.67B | $1.87B | $1.94B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $124.00M | $113.70M | $224.50M | $316.60M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 27.60M | 30.40M | 34.70M | 35.60M |